|
|
Volumn 22, Issue 4, 1996, Pages 265-276
|
|
Phase II of the AHCPR-sponsored heart failure guideline: translating practice recommendations into review criteria.
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ARTICLE;
CLINICAL PRACTICE;
CONGESTIVE HEART FAILURE;
COST BENEFIT ANALYSIS;
DRUG COMBINATION;
ECONOMICS;
FEASIBILITY STUDY;
GOVERNMENT;
HEALTH CARE QUALITY;
HUMAN;
MULTIMODALITY CANCER THERAPY;
PRACTICE GUIDELINE;
TREATMENT OUTCOME;
UNITED STATES;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
COMBINED MODALITY THERAPY;
COST-BENEFIT ANALYSIS;
DRUG THERAPY, COMBINATION;
FEASIBILITY STUDIES;
HEART FAILURE, CONGESTIVE;
HUMANS;
OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);
PHYSICIAN'S PRACTICE PATTERNS;
PRACTICE GUIDELINES;
QUALITY ASSURANCE, HEALTH CARE;
UNITED STATES;
UNITED STATES AGENCY FOR HEALTHCARE RESEARCH AND QUALITY;
|
|
EID: 0030122412
PISSN: 10703241
EISSN: None
Source Type: Journal
DOI: 10.1016/S1070-3241(16)30230-9 Document Type: Article |
|
Times cited : (30)
|
|
References (0)
|
